Search results
War of the Wordle: New York Times in legal row with geography-based spinoff
The Independent via Yahoo News· 7 days agoA New York Times Co. spokesperson said the company has no issue with people creating...version” of...
Over Easy: Sunday morning coming down
Valley News· 8 hours agoOn Sunday morning there is a moment when I hesitate before I head out the door to scoop up our newspaper from the driveway. The Sunday paper is no more....
Washington Post executive editor steps down in surprise move, just months before November election
Fox News via Yahoo News· 4 days agoOver a decade later, the paper faced battles with staying profitable. Many staffers characterized...
Former FWP director refutes account of Gianforte wolf kill published by New York Times
Billings Gazette· 3 days agoFish, Wildlife & Parks, on Monday refuted allegations made in a June 2 New York Times story in which...
The Brits Invade US Newsrooms With a ‘Killer Instinct’ and Fleet Street Ethics
The Wrap via Yahoo News· 2 days agoRobert Winnett, the soon-to-be executive editor of the Washington Post, is the latest British...
Epoch Times Executive Accused of Laundering $67 Million
New York Times· 3 days agoWeidong Guan was charged with three counts in a scheme that the Justice Department said caused...
Boomers Love Saying 'Back in My Day, It Was Cheaper.' But Was It?
CNET· 16 hours agoYounger generations will never understand the struggle of having a house full of people but only one...
The artist 'not surprised' to be a best-seller
BBC via Yahoo News· 4 days agoArtTactic has also found that while the global art market declined by 18% last year, Africa's only shrank by 8.4%. In its 2024 assessment of the industry
Will Netflix get into the TV news business? Here are the pros and cons
LA Times via Yahoo News· 18 hours agoYounger consumers are bypassing traditional TV and not developing the habit of news viewing...
JD Supra: Better Health Care Newsletter
JD Supra· 12 hours agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.